Literature DB >> 17507042

Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.

Petter Hedlund1, Tomi Streng, Tack Lee, Karl-Erik Andersson.   

Abstract

PURPOSE: The beneficial effects of antimuscarinics on detrusor overactivity and overactive bladder syndrome are exerted during bladder filling, when there is no parasympathetic outflow from the spinal cord. We tested the hypothesis that, if tolterodine exerts some of its effects on afferent nerves, the functional elimination of C-fiber afferents should affect the actions of the drug on urodynamic parameters.
MATERIALS AND METHODS: The study was performed in normal female Sprague Dawley rats and rats treated with resiniferatoxin to eliminate vanilloid sensitive afferent nerves. Tolterodine was given intravenously to normal and resiniferatoxin treated animals. To test if tolterodine at the doses used affects efferent neurotransmission the drug was given to normal and resiniferatoxin treated animals in which detrusor activity was induced by apomorphine.
RESULTS: In resiniferatoxin treated animals (0.3 mg kg-1 subcutaneously) the mean micturition interval and volume, and mean residual volume increased significantly compared to those in controls. Baseline and micturition pressures in control and resiniferatoxin treated animals were similar, whereas threshold pressures were higher in resiniferatoxin treated animals. In controls 10 microg kg-1 tolterodine administered intravenously increased the mean micturition interval, bladder capacity and micturition volume. In resiniferatoxin treated rats 1 and 10 microg kg-1 tolterodine increased the mean micturition interval, bladder capacity and micturition volume. Subcutaneous administration of 100 microg kg-1 apomorphine induced detrusor overactivity in all rats. The AUC of intravesical pressure during the initial 10 minutes from the start of detrusor overactivity showed no difference between normal and resiniferatoxin treated rats with or without tolterodine pretreatment.
CONCLUSIONS: Tolterodine increased the micturition interval and bladder capacity in controls and in resiniferatoxin treated animals, suggesting that these effects were exerted independently of resiniferatoxin sensitive afferents. Tolterodine did not decrease the contractile effects of apomorphine at the doses used, suggesting that the drug had no effect on efferent neurotransmission during voiding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507042     DOI: 10.1016/j.juro.2007.03.006

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Urothelial effects of oral agents for overactive bladder.

Authors:  Karl-Erik Andersson; Claudius Fullhase; Roberto Soler
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

2.  In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats.

Authors:  Takanobu Yamazaki; Yukiko Muraki; Tsuyoshi Anraku
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-08-05       Impact factor: 3.000

3.  Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery.

Authors:  Fabio Castiglione; Alice Bergamini; Arianna Bettiga; Trinity J Bivalacqua; Fabio Benigni; Frank Strittmatter; Giorgio Gandaglia; Patrizio Rigatti; Francesco Montorsi; Petter Hedlund
Journal:  Eur Urol       Date:  2012-04-19       Impact factor: 20.096

4.  Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization.

Authors:  Tirsit S Asfaw; Joseph Hypolite; Gina M Northington; Lily A Arya; Alan J Wein; Anna P Malykhina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

Review 5.  The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy.

Authors:  Karl-Erik Andersson; Nurul Choudhury; Jean-Nicolas Cornu; Moses Huang; Cees Korstanje; Emad Siddiqui; Philip Van Kerrebroeck
Journal:  Ther Adv Urol       Date:  2018-07-06

6.  Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats.

Authors:  Katsuaki Ito; Akihito Iwami; Hiromi Katsura; Masahiro Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-05       Impact factor: 3.000

Review 7.  Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

Authors:  Kyu-Sung Lee; Hye Won Lee; Deok Hyun Han
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

8.  Combination of foot stimulation and tolterodine treatment eliminates bladder overactivity in cats.

Authors:  Zeyad Schwen; Yosuke Matsuta; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Neurourol Urodyn       Date:  2013-08-29       Impact factor: 2.696

Review 9.  Development of oxybutynin chloride topical gel for overactive bladder.

Authors:  Vincent R Lucente; David R Staskin; Elise De
Journal:  Open Access J Urol       Date:  2011-04-04

Review 10.  Oxybutynin topical gel in the treatment of overactive bladder.

Authors:  G Willy Davila
Journal:  Open Access J Urol       Date:  2010-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.